At a glance
- Originator Asahi Kasei
- Class Neuroprotectants; Nootropics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 14 Jan 1998 No-Development-Reported for Alzheimer's disease in Japan (Unknown route)
- 22 Mar 1996 New profile
- 22 Mar 1996 Investigation in Alzheimer's disease in Japan (Unknown route)